ARTICLE | Company News
Myriad Genetics, OncorMed diagnostics/imaging, cancer news
April 15, 2013 7:00 AM UTC
MYGN filed suit in the U.S. District Court for the District of Utah alleging that ONM is infringing MYGN's U.S. Patent No. 5,693,473 covering mutations in the BRCA1 gene that increase a woman's risk ...